Clinical trial
Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed…
NCT00477971 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00477971 |
|---|---|
| Title | Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis |
| Official title | Phase III Trial of Stem Cell Transplantation Compared to Parenteral Melphalan and Oral Dexamethasone in the Treatment of Primary Systemic Amyloidosis (AL) |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, dexamethasone, melphalan, autologous hematopoietic stem cell transplantation |
| Enrollment | 89 |
| Start date | Oct 1, 2005 |
| Primary completion | Jul 1, 2012 |
| Completion | Dec 1, 2014 |
| First posted | May 24, 2007 |
| Last update posted | May 17, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: